Nuclear factor-κB (NF-κB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy

Oral Oncology

Volumn 43, Issue 4, 2007, Pages 395-401

  Logan, Richard M ^a,b   Gibson, Rachel J ^c,d   Sonis, Stephen T ^e   Keefe, Dorothy M K ^c,d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Chemotherapy; COX 2; NF B; Oral mucositis

Indexed keywords

BLEOMYCIN; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; DACARBAZINE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHOTREXATE; PREDNISOLONE; STREPTOZOCIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LUNG CANCER; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; ORAL BIOPSY; PALLIATIVE THERAPY; PANCREAS CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; BIOSYNTHESIS; BREAST TUMOR; COLORECTAL TUMOR; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METABOLISM; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; PILOT STUDY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MOUTH MUCOSA; NF-KAPPA B; PANCREATIC NEOPLASMS; PILOT PROJECTS;

EID: 33947198190     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2006.04.011     Document Type: Article

References (25)

1. Scully C., Epstein J., and Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: Part 1, pathogenesis and prophylaxis of mucositis. Head Neck 25 (2003) 1057-1070
2. Scully C., Epstein J., and Sonis S.T. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck 26 (2004) 77-84
3. Sharma R., Tobin P., and Clarke S.J. Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea. The Lancet Oncol 6 (2005) 93-102
4. Keefe D.M.K. Gastrointestinal mucositis: a new biological model. Support Care Cancer 12 (2004) 6-9
5. Keefe D.M.K., Brealey J., Goland G.J., and Cummins A.G. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 47 (2000) 632-637
6. Pico J.-L., Avila-Garavito A., and Naccache P. Mucositis: Its occurrence, consequences, and treatment in the oncology setting. The Oncologist 3 (1998) 446-451
7. Keefe D.M., Gibson R.J., and Hauer-Jensen M. Gastrointestinal mucositis. Semin Oncol Nurs 20 (2004) 38-47
8. Spielberger R., Stiff P., Bensinger W., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351 (2004) 2590-2598
9. Rubenstein E.B., Peterson D., Schubert M., et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100 (2004) 2026-2046
10. Elting L.S., Cooksley C., Chambers M.S., Cantor S.B., Manzullo E., and Rubenstein E.B. The burdens of cancer therapy: Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98 (2003) 1531-1539
11. Sonis S.T., Elting L.S., Keefe D., Peterson D.E., Schubert M., Hauer-Jensen, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100 (2004) 1995-2025
12. Bellm L.A., Epstein J.B., Rose-Ped A., Martin P., and Fuchs H.J. Patient reports of complications of bone marrow transplantation. Support Care Cancer 8 (2000) 33-39
13. Gibson R.J., Cummins A.G., Bowen J.M., Logan R.M., Healey T., and Keefe D.M. Apoptosis occurs early in the basal layer of the oral mucosa following cancer chemotherapy. Asian Pac J Clin Oncol 2 (2006) 39-49
14. Kim J.-H., Lee K.W., Lee M.-W., Lee H.J., Kim S.-H., and Surh Y.-J. Hirsutenone inhibits phorbol ester-induced upregulation of COX-2 and MMP-9 in cultured human mammary epithelial cells: NF-κB as a potential molecular target. FEBS Lett 580 (2006) 385-392
15. *Phys 63 (2005) 1295-1303
16. Krajewska M., Wang H.G., Krajewski S., Zapata J.M., Shabaik A., Gascoyne R., et al. Immunohistochemical analysis of in vivo patterns of expression of CPP32 (Caspase-3), a cell death protease. Cancer Res 57 (1997) 1605-1613
17. Krajewski S., Krajewska M., and Reed J.C. Immunohistochemical analysis of in vivo patterns of Bak expression, a proapoptotic member of the Bcl-2 protein family. Cancer Res 56 (1996) 2849-2855
18. Krajewska M., Zapata J.M., Meinhold-Heerlein I., Hedayat H., Monks A., Bettendorf H., et al. Expression of Bcl-2 family member Bid in normal and malignant tissues. Neoplasia 4 (2002) 129-140
19. Inc. SI. SAS/STAT User's Guide, Cary, Version 6. 4th ed., NC: SAS Institute Inc., 1989.
20. Sonis S.T., O'Donnell K.E., Popat R., Bragdon C., Phelan S., Cocks D., et al. The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis. Oral Oncol 40 (2004) 170-176
21. Aota K., Azuma M., Yamashita T., Tamatani T., Motegi K., Ishimaru N., et al. 5-Fluorouracil induces apoptosis through the suppression of NF-κB activity in human salivary gland cancer cells. Biochem Biophys Res Commun 273 (2000) 1168-1174
22. Azuma M., Yamashita T., Aota K., Tamatani T., and Sato M. 5-Fluorouracil suppression of NF-κB is mediated by the inhibition of IκB kinase activity in human salivary gland cancer cells. Biochem Biophys Res Commun 282 (2001) 292-296
23. Paris F., Fuks Z., Kang A., Capodieci P., Juan G., Ehleiter D., et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293 (2001) 293-297
24. Kuwano T., Nakao S., Yamamoto H., Tsuneyoshi M., Yamamoto T., Kuwano M., et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. Faseb J 18 (2004) 300-310
25. Sonis S.T. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 34 (1998) 39-43